March 26, 2021Act, active, advertised, advertising, analysis, analytics, and Cosmetic, approval, business, cannabidiol, cannabis, cbd, compliance, consumer, Dispensaries & Retail, drug, FDA, FDA food safety challenge, Federal, food, GMP, good manufacturing practice, government, growing, Husch Blackewell, inactive, industry, ingredient, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, marketing, medical, medicine, NDA, New Drug Application, nonprescription, OTC, prescription, product, products, Quality, recreational, regulation, regulations, regulatory, retail, safety, state, test, Testing, thc, violation, warning FDA Issues Warning Letters on Marketing and Sale of OTC CBD Products The U.S. Food and Drug Administration (FDA) issued warning letters this month to two companies concerning the marketing and sale of over-the-counter (OTC) drug […]